Back to top
more

Merit Medical Systems (MMSI)

(Delayed Data from NSDQ)

$88.74 USD

88.74
1,093,175

+4.62 (5.49%)

Updated Aug 2, 2024 04:00 PM ET

After-Market: $88.71 -0.03 (-0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 15% (214 out of 251)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Analysts Estimate Merit Medical (MMSI) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Merit Medical (MMSI) Looks Good: Stock Adds 6.7% in Session

by Zacks Equity Research

Merit Medical (MMSI) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

Here's Why You Should Retain Merit Medical (MMSI) for Now

by Zacks Equity Research

Investor confidence is high on Merit Medical (MMSI) stock, thanks to solid prospects.

Merit Medical (MMSI) Up 18.4% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Merit Medical (MMSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why You Should Retain Merit Medical (MMSI) for Now

by Zacks Equity Research

Investor confidence is high in Merit Medical (MMSI) stock, thanks to solid prospects.

Merit Medical (MMSI) Tops Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Merit Medical Systems (MMSI) has registered an increase in revenues at both its key operating segments in Q1

Merit Medical (MMSI) Q1 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Merit Medical (MMSI) delivered earnings and revenue surprises of 40.74% and 5.17%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Here's Why You Should Retain NextGen Healthcare Stock Now

by Zacks Equity Research

NextGen Healthcare (NXGN) continues to benefit from growing RCM and EHR markets, and robust demand for other NextGen solutions.

Here's Why You Should Hold on to HMS Holdings Stock Now

by Zacks Equity Research

HMS Holdings (HMSY) continues to benefit from strong PI solutions and TPM. However, stiff competition remains a concern.

Masimo Collaborates With Samsung to Help Fight Coronavirus

by Zacks Equity Research

Masimo (MASI) and Samsung Electronics America collaborate to bring Masimo SafetyNet Patient App on the latter's select smartphones for faster distribution of Masimo SafetyNet to COVID-19 patients.

Here's Why You Should Hold on to Cerner (CERN) Stock Now

by Zacks Equity Research

Cerner (CERN) continues to gain from solid prospects in EHR and strategic deals. However, margin contraction remains a woe.

Earnings Preview: Merit Medical (MMSI) Q1 Earnings Expected to Decline

by Zacks Equity Research

Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ResMed (RMD) Grows on Stellar Mask Sales, SaaS Capabilities

by Zacks Equity Research

Within SaaS, ResMed (RMD) shows strong momentum in the Brightree service portfolio.

Here's Why You Should Hold on to Luminex (LMNX) Stock Now

by Zacks Equity Research

Luminex (LMNX) continues to benefit from robust product portfolio, solid molecular diagnostics and ARIES platforms.

BD (BDX) Receives EUA for New Coronavirus Detection Test

by Zacks Equity Research

Becton, Dickinson (BDX) receives EUA from the FDA for another molecular diagnostic test for COVID-19, which can return results in two to three hours.

Here's Why You Should Invest in Cooper Companies (COO) Stock

by Zacks Equity Research

Cooper Companies (COO) continues to gain traction from its robustly performing CVI and CSI businesses.

Masimo SafetyNet to Help Clinicians Fight Coronavirus Better

by Zacks Equity Research

Masimo (MASI) announces the full market release of Masimo SafetyNet, which is a remote patient management solution that will help in the fight against the COVID-19 pandemic.

MMSI vs. CNMD: Which Stock Is the Better Value Option?

by Zacks Equity Research

MMSI vs. CNMD: Which Stock Is the Better Value Option?

AngioDyanamics (ANGO) Q3 Earnings and Revenues Top Estimates

by Zacks Equity Research

AngioDynamics (ANGO) fiscal third-quarter results benefit from strong growth across all businesses and higher revenues.

Here's Why You Should Hold on to Stryker (SYK) Stock Now

by Zacks Equity Research

Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako, broad product portfolio and solid international growth. However, pricing pressure raises concern.

Merit Medical WRAPSODY Gets 2 FDA Breakthrough Device Nods

by Zacks Equity Research

This regulatory clearance is expected to bolster Merit Medical Systems' (MMSI) cardiovascular segment.

Here's Why You Should Hold on to Avanos Medical Stock Now

by Zacks Equity Research

Avanos Medical (AVNS) continues to benefit from strong performing segments and robust product portfolio. However, weak performance at Acute Pain unit raises concern.

Here's Why You Should Add Integer Holdings to Your Portfolio

by Zacks Equity Research

Integer Holdings (ITGR) continues to gain traction from solid presence in the broader MedTech space and portfolio management.

Merit Medical (MMSI) Down 24.4% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Merit Medical (MMSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why You Should Retain Merit Medical (MMSI) Stock Now

by Zacks Equity Research

Merit Medical (MMSI) continues to benefit from growing product pipeline, strong R&D focus and strategic acquisitions.